DUALITY ADVISERS, LP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
DUALITY ADVISERS, LP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,543,471
+178.2%
40,405
+162.6%
0.19%
+167.1%
Q2 2023$554,901
-79.0%
15,384
-77.8%
0.07%
-76.7%
Q1 2023$2,646,300
+24.1%
69,293
+84.9%
0.30%
+23.5%
Q4 2022$2,132,953
+341.6%
37,486
+209.5%
0.24%
+367.3%
Q1 2022$483,000
-86.9%
12,113
-86.6%
0.05%
-81.6%
Q3 2021$3,690,000
+344.6%
90,705
+355.6%
0.28%
+293.1%
Q1 2021$830,000
-22.0%
19,907
-50.8%
0.07%
+5.9%
Q3 2020$1,064,000
+20.0%
40,490
+22.4%
0.07%
-16.0%
Q2 2020$887,000
+124.0%
33,078
+48.1%
0.08%
+237.5%
Q4 2019$396,00022,3350.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders